Speaker Profile
M.D., Pediatric Oncologist, Stanford
Biography
I am a pediatric oncologist actively pursuing immunotherapy research with a focus on translating cellular therapies. In the laboratory, I engaged in CAR T cell engineering and studies of T cell subset optimization for adoptive transfer. I lead early phase clinical trials studying alternatives to CD19-monospecific targeting, including bispecific CAR and CD22 CAR development, and am a co-investigator studying GD2-specific CAR T cell therapy for fatal brainstem tumors. In efforts to expand our knowledge of real world performance of CAR T cell therapy, I founded and chair the Pediatric Real-world CAR Consortium (PRWCC), a consortium with 38 participating core institutions and a mission to foster collaboration and create a forum for multi-institutional data and sample sharing. This is a growing collaborative network that is poised towards advancing outcomes following immunotherapy for pediatric cancers.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Keith Yamamoto, UCSF
- PMWC 2024 Award Ceremony:
Luminary Honoree: Geoff Ginsburg, NIH (All of Us)
- Fireside Chat: Geoff Ginsburg, NIH and Keith Yamamoto, UCSF
- New Federal Programs Driving Transformative Health Breakthroughs (PANEL)
Chair: Keith Yamamoto, UCSF
- Arunan Skandarajah, ARPA-H
- Susan Marqusee, NSF
- Sheng Lin-Gibson, NIST - AI-driven Advances in Precision Medicine (PANEL)
Chair: Sharat Israni, Bakar Institute, UCSF
- Suzanne Tamang, Stanford
- Colleen Clancy, UC Davis
- Nevan Krogan, UCSF
- Lauren Erdman, University of Toronto - Precision Medicine in New Research Frameworks (PANEL)
Chair: Regis B. Kelly, UCSF
- Joe DeRisi, UCSF
- Luke Gilbert, UCSF
- Prachee Avasthi, Arcadia Science - Living Therapeutics for Precision Medicine
Chair: Michelle Hermiston, UCSF
- Peter Marks, FDA
- Wendell Lim, UCSF
- Liora Schultz, Stanford - AI and Precision Medicine: Navigating Equity and Social Justice Challenges (PANEL)
Chair: Hank Greely, Stanford
- Ziad Obermeyer, UC Berkeley
- Sara L. Ackerman, UCSF
